Mark A. Reddish
National Institute of Mental Health(US)
Publications by Year
Research Areas
Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Streptococcal Infections and Treatments, Antimicrobial Resistance in Staphylococcus
Most-Cited Works
- → Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers(2005)304 cited
- → Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2(1998)300 cited
- → The Selectivity and Functional Connectivity of the Anterior Temporal Lobes(2009)249 cited
- → Immunogenicity of a 26-Valent Group A Streptococcal Vaccine(2002)242 cited
- → Antibodies Against Mucin-Associated Sialyl-Tn Epitopes Correlate with Survival of Metastatic Adenocarcinoma Patients Undergoing Active Specific Immunotherapy with Synthetic STn Vaccine(1996)183 cited
- → Safety and Immunogenicity of a Recombinant Multivalent Group A Streptococcal Vaccine in Healthy Adults(2004)172 cited
- → Enhancing the Effect of THERATOPE STn-KLH Cancer Vaccine in Patients with Metastatic Breast Cancer by Pretreatment with Low-Dose Intravenous Cyclophosphamide(1996)157 cited
- → Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide(1998)129 cited
- → Evidence of a Cellular Immune Response Against Sialyl-Tn in Breast and Ovarian Cancer Patients After High-Dose Chemotherapy, Stem Cell Rescue, and Immunization with Theratope STn-KLH Cancer Vaccine(1999)120 cited
- → Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene(1993)114 cited